Next |
home / stock / mrna / mrna message board
Subject | By | Source | When |
---|---|---|---|
Cathie Wood's ARK Innovation ETF buys shares of | axelvento | investorshub | 05/01/2023 4:39:04 AM |
Believe in what | Vexari | investorshub | 05/01/2023 4:25:38 AM |
the important thing is to believe not to hope! | axelvento | investorshub | 05/01/2023 4:14:06 AM |
The thought of overthinking without explanation | Vexari | investorshub | 04/30/2023 8:03:20 PM |
Without understanding | Vexari | investorshub | 04/29/2023 9:23:49 PM |
Making good personal choices in one's health care regimen | Vexari | investorshub | 04/29/2023 7:58:32 PM |
Germ ~~ virus theory is not a theory | Vexari | investorshub | 04/28/2023 11:38:41 PM |
Covid vaccine maker is sitting on $18bn and | axelvento | investorshub | 04/28/2023 4:18:00 AM |
For my second pick, I'm swinging for the | axelvento | investorshub | 04/28/2023 4:12:39 AM |
I find value in your desperation....over thinking! | axelvento | investorshub | 04/28/2023 3:24:38 AM |
Desperation, is beginning to show itself | Vexari | investorshub | 04/27/2023 10:41:53 PM |
Really | Vexari | investorshub | 04/27/2023 9:59:45 PM |
Florida surgeon general altered Covid-19 vaccine analysis to | axelvento | investorshub | 04/27/2023 4:30:40 AM |
Government involvement | Vexari | investorshub | 04/26/2023 8:31:50 PM |
Construction commences at Moderna Innovation and Technology Centre | axelvento | investorshub | 04/26/2023 11:56:40 AM |
imo...i have millions upon millions of quiet followers | IHuser | investorshub | 04/22/2023 3:12:27 AM |
Bancel's sell program has been consistent. Selling | FooBarAndGrill | investorshub | 04/20/2023 6:15:56 PM |
Moderna and IBM- | axelvento | investorshub | 04/20/2023 12:06:20 PM |
RSV vaccine approval should be a top priority | axelvento | investorshub | 04/20/2023 11:57:24 AM |
They just wanted to drop the price so | Civil War General | investorshub | 04/18/2023 11:08:13 AM |
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, MA / ACCESSWIRE / July 10, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, August 1, 2024 to report its second quarter 2024 financial results, and provide a corporate update. A live webcast of the c...
CAMBRIDGE, MA AND OSAKA, JAPAN / ACCESSWIRE / July 8, 2024 / Moderna, Inc. (Nasdaq:MRNA) and Mitsubishi Tanabe Pharma Corporation today announced that the companies have entered into a joint agreement regarding the co-promotion of Moderna's mRNA respiratory vaccine portfolio in Japan, including ...
CAMBRIDGE, MA / ACCESSWIRE / July 2, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced a project award of $176 million through the Rapid Response Partnership Vehicle (RRPV) to accelerate the development of mRNA-based pandemic influenza vaccines. The RRPV is a Consortium funded by the Biomedical...